Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.30 | N/A | -22.08% |
management commentary, guidance changes, and full analysis available with Pro.
| -22.08% |
Tone: Defensive
Overall, management expressed concerns about market conditions impacting performance. They are prioritizing operational efficiency to navigate these challenges.
Management acknowledged challenges in the current market environment.
They emphasized a focus on cost control and efficiency improvements.
The earnings report indicates that Prestige Consumer HE faced challenges, resulting in a notable EPS miss. The stock reacted negatively, dropping 9.08% as investors digested the disappointing results and management's cautious tone regarding market conditions. Without any guidance, uncertainty remains about the company's future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
TAKE-TWO INTERACTIVE
Feb 3, 2014